Huiyu Pharmaceutical: Shareholder Huang Ganyi plans to passively reduce holdings by no more than 1%

Huayu Pharmaceuticals announced that shareholder Huang Ganyi holds 25.9194 million shares, accounting for 6.119%, of which 19.6283 million shares are under judicial execution, accounting for 4.634%. It is planned to passively reduce no more than 4.236 million shares, not exceeding 1%, through centralized bidding from May 19, 2026 to August 16, 2026. Prior to this, 1.3 million shares were already reduced from February 9, 2026 to February 10, 2026, accounting for 0.307%, with a price of 19.41-19.77 yuan per share.